Madiha Fida1,2, Sarwat Khalil1,3, Omar Abu Saleh1, Douglas W Challener1, Muhammad Rizwan Sohail1,4, Joshua N Yang2, Bobbi S Pritt2, Audrey N Schuetz2, Robin Patel1,2. 1. Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA. 2. Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA. 3. Division of Infectious Disease and International Medicine, Department of Medicine, University of Minnesota, Minneapolis, MN, USA. 4. Division of Infectious Disease, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA.
Abstract
BACKGROUND: Accurate microbiologic diagnosis is important for appropriate management of infectious diseases. Sequencing-based molecular diagnostics are increasingly used for precision diagnosis of infections. However, their clinical utility is unclear. METHODS: We conducted a retrospective analysis of specimens that underwent 16S ribosomal RNA (rRNA) gene polymerase chain reaction (PCR) followed by Sanger sequencing at our institution from April 2017 through March 2019. RESULTS: A total of 566 specimens obtained from 460 patients were studied. Patients were considered clinically infected or noninfected based on final diagnosis and management. In 17% of patients, 16S rRNA PCR/sequencing was positive and in 5% of patients, this test led to an impact on clinical care. In comparison, bacterial cultures were positive in 21% of patients. Specimens with a positive Gram stain had 12 times greater odds of having a positive molecular result than those with a negative Gram stain (95% confidence interval for odds ratio, 5.2-31.4). Overall, PCR positivity was higher in cardiovascular specimens (37%) obtained from clinically infected patients, with bacterial cultures being more likely to be positive for musculoskeletal specimens (P < .001). 16S rRNA PCR/sequencing identified a probable pathogen in 10% culture-negative specimens. CONCLUSION: 16S rRNA PCR/sequencing can play a role in the diagnostic evaluation of patients with culture-negative infections, especially those with cardiovascular infections.
BACKGROUND: Accurate microbiologic diagnosis is important for appropriate management of infectious diseases. Sequencing-based molecular diagnostics are increasingly used for precision diagnosis of infections. However, their clinical utility is unclear. METHODS: We conducted a retrospective analysis of specimens that underwent 16S ribosomal RNA (rRNA) gene polymerase chain reaction (PCR) followed by Sanger sequencing at our institution from April 2017 through March 2019. RESULTS: A total of 566 specimens obtained from 460 patients were studied. Patients were considered clinically infected or noninfected based on final diagnosis and management. In 17% of patients, 16S rRNA PCR/sequencing was positive and in 5% of patients, this test led to an impact on clinical care. In comparison, bacterial cultures were positive in 21% of patients. Specimens with a positive Gram stain had 12 times greater odds of having a positive molecular result than those with a negative Gram stain (95% confidence interval for odds ratio, 5.2-31.4). Overall, PCR positivity was higher in cardiovascular specimens (37%) obtained from clinically infected patients, with bacterial cultures being more likely to be positive for musculoskeletal specimens (P < .001). 16S rRNA PCR/sequencing identified a probable pathogen in 10% culture-negative specimens. CONCLUSION: 16S rRNA PCR/sequencing can play a role in the diagnostic evaluation of patients with culture-negative infections, especially those with cardiovascular infections.
Authors: Besu F Teshome; Scott Martin Vouri; Nicholas Hampton; Marin H Kollef; Scott T Micek Journal: Pharmacotherapy Date: 2019-01-07 Impact factor: 4.705
Authors: J Bador; B Nicolas; A Chapuis; V Varin; N Dullier-Taillefumier; C de Curraize; L Amoureux; A Putot; C Neuwirth Journal: Med Mal Infect Date: 2019-10-11 Impact factor: 2.152
Authors: Tinzar Basein; Bradley J Gardiner; Gabriela M Andujar Vazquez; Andrew S Joel Chandranesan; Arthur R Rabson; Shira Doron; David R Snydman Journal: Open Forum Infect Dis Date: 2018-10-10 Impact factor: 3.835
Authors: Timothy L Tan; Michael M Kheir; Noam Shohat; Dean D Tan; Matthew Kheir; Chilung Chen; Javad Parvizi Journal: JB JS Open Access Date: 2018-07-12
Authors: Laure Flurin; Matthew J Wolf; Cody R Fisher; Edison J Cano Cevallos; James J Vaillant; Bobbi S Pritt; Daniel C DeSimone; Robin Patel Journal: J Clin Microbiol Date: 2022-08-30 Impact factor: 11.677
Authors: Peter Paul C Lim; Lisa M Stempak; Sindhoosha Malay; LeAnne N Moore; Sree Sarah S Cherian; Ankita P Desai Journal: Antibiotics (Basel) Date: 2022-01-26